SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-249878
Filing Date
2010-11-05
Accepted
2010-11-05 14:47:55
Documents
8
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 716785
2 AMENDED AND RESTATED LICENSE, DEVELOPMENT AND MARKETING AGREEMENT dex101.htm EX-10.1 160299
3 STOCK OPTION AGREEMENT BETWEEN INSPIRE PHARMACEUTICALS, INC. dex102.htm EX-10.2 34360
4 RESTRICTED STOCK UNIT AGREEMENT BETWEEN INSPIRE PHARMACEUTICALS, INC. dex103.htm EX-10.3 25973
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 10028
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10144
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4077
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4098
  Complete submission text file 0001193125-10-249878.txt   967182
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 101168200
SIC: 2834 Pharmaceutical Preparations